Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,827 | -121,290 | -31,544 | -23,376 | -18,148 |
| Depreciation Amortization | 67 | 34 | 5,893 | 1,943 | 773 |
| Income taxes - deferred | 14 | 7 | 14 | 23 | 15 |
| Accounts receivable | N/A | N/A | N/A | N/A | -38 |
| Accounts payable and accrued liabilities | 208 | 470 | -2,436 | -2,094 | -2,131 |
| Other Working Capital | -114,635 | -1,263 | -9,240 | -9,325 | -5,686 |
| Other Operating Activity | 114,688 | 115,840 | 6,633 | 4,915 | 4,137 |
| Operating Cash Flow | $-22,485 | $-6,202 | $-30,680 | $-27,914 | $-21,078 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 25 | 25 | 25 |
| Other Investing Activity | 356 | 356 | -158 | -158 | -158 |
| Investing Cash Flow | $356 | $356 | $-133 | $-133 | $-133 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -21,244 | -21,244 | -6,000 |
| Common Stock Issued | N/A | N/A | 46,286 | 46,285 | 20,346 |
| Other Financing Activity | 108,140 | 108,612 | 0 | 0 | 0 |
| Financing Cash Flow | $108,140 | $108,612 | $25,042 | $25,041 | $14,346 |
| Beginning Cash Position | 7,546 | 7,546 | 13,318 | 13,318 | 13,318 |
| End Cash Position | 93,557 | 110,312 | 7,547 | 10,312 | 6,453 |
| Net Cash Flow | $86,011 | $102,766 | $-5,771 | $-3,006 | $-6,865 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,485 | -6,202 | -30,680 | -27,914 | -21,078 |
| Free Cash Flow | -22,485 | -6,202 | -30,680 | -27,914 | -21,078 |